BSX EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
BSX's ev/ebitda is lower than 95% of the last 10 years.
EV/EBITDA History
BSX EV/EBITDA by year
Yearly range of BSX’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 13.2 to 113.2, averaging 32.2.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 13.2 | 19.3 | 32.2 | 13.9 |
| 2025 | 29.5 | 36.5 | 43.0 | 31.2 |
| 2024 | 27.1 | 33.5 | 38.7 | 36.6 |
| 2023 | 24.1 | 28.1 | 30.9 | 28.2 |
| 2022 | 22.4 | 26.7 | 30.5 | 30.0 |
| 2021 | 23.4 | 36.8 | 47.7 | 27.2 |
| 2020 | 21.1 | 38.6 | 56.0 | 43.8 |
| 2019 | 20.6 | 25.6 | 33.5 | 33.5 |
| 2018 | 19.9 | 23.0 | 26.3 | 21.9 |
| 2017 | 21.5 | 31.4 | 41.7 | 21.5 |
| 2016 | 97.9 | 105.2 | 113.2 | 104.3 |
Get notified when BSX EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is BSX EV/EBITDA High or Low Right Now?
Boston Scientific Corporation's EV/EBITDA is currently 13.9, which is near historic low relative to its 10-year historical range. The 10-year median EV/EBITDA for BSX is approximately 29.2. See all BSX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.